World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
60
Citations
14452
World Ranking
3101
National Ranking
21

Cheol-In Kang publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Cheol-In Kang sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 343 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Cheol-In Kang D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Cheol-In Kang sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 60 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Cheol-In Kang is affiliated with Sungkyunkwan University in South Korea and focuses primarily on the field of Medicine, with a significant emphasis on Infectious Diseases. Their research output includes extensive work in Epidemiology, Molecular Medicine, Clinical Biochemistry, and Pharmacology.

The scientist's main research topics encompass:

  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Antibiotics Pharmacokinetics and Efficacy
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Antifungal resistance and susceptibility

A number of recent publications led or coauthored by Cheol-In Kang illustrate areas of active investigation, including:

  • Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data, 2020, Clinical Infectious Diseases
  • Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays, 2022, Frontiers in Cellular and Infection Microbiology
  • Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine, 2021, Frontiers in Immunology
  • Severe Thrombocytopenia in a Patient with COVID-19, 2020, Infection and Chemotherapy
  • Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review, 2021, Infection and Chemotherapy

Frequent coauthors with whom Cheol-In Kang has collaborated include:

  • Doo Ryeon Chung
  • Kyong Ran Peck
  • Kyungmin Huh
  • Sun Young Cho
  • Jae-Hoon Ko

The scientist has published regularly in several specific research venues, notably:

  • Open Forum Infectious Diseases
  • International Journal of Antimicrobial Agents
  • Infection and Chemotherapy
  • European Journal of Clinical Microbiology & Infectious Diseases
  • Microbiology Spectrum

Best Publications

  • Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome

    Cheol-In Kang;Sung-Han Kim;Hong-Bin Kim;Sang-Won Park

  • Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study

    Jae-Hoon Song;Po-Ren Hsueh;Doo Ryeon Chung;Kwan Soo Ko

  • Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

    So Hyun Kim;Jae Hoon Song;Doo Ryeon Chung;Visanu Thamlikitkul

  • High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

    Doo Ryeon Chung;Jae Hoon Song;So Hyun Kim;Visanu Thamlikitkul

  • Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

    Kwan Soo Ko;Ji Yoeun Suh;Ki Tae Kwon;Sook-In Jung

  • Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience

    Jae Hoon Ko;Hyeri Seok;Sun Young Cho;Young Eun Ha

  • MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

    Sun Young Cho;Ji-Man Kang;Young Eun Ha;Ga Eun Park

  • Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae

    Hyunjoo Pai;Cheol In Kang;Jeong Hum Byeon;Ki Deok Lee

  • Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.

    Jae-Hoon Song;Won Sup Oh;Cheol-In Kang;Doo Ryeon Chung

  • Clinical Significance and Outcome of Nosocomial Acquisition of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis

    Hae Suk Cheong;Cheol-In Kang;Jeong A Lee;Soo Youn Moon

  • Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections.

    Cheol-In Kang;Jieun Kim;Dae Won Park;Baek-Nam Kim

  • Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications

    Cheol-In Kang;Jae-Hoon Song

  • High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination

    Mi Young Lee;Kwan Soo Ko;Cheol-In Kang;Doo Ryeon Chung

  • Outcome of Staphylococcus aureus Bacteremia in Patients with Eradicable Foci versus Noneradicable Foci

    Sung-Han Kim;Wan-Bum Park;Ki-Deok Lee;Cheol-In Kang

  • Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

    Cheol-In Kang;Sung-Han Kim;Dong Min Kim;Wan Beom Park

  • Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance

    Cheol In Kang;Sung Han Kim;Ji Whan Bang;Hong Bin Kim

  • Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients.

    Jae Hoon Ko;Ga Eun Park;Ji Yeon Lee;Ji Yong Lee

  • Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea

    D. R. Chung;H. Lee;M. H. Park;S.-I. Jung

  • Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea

    Won Suk Choi;Cheol In Kang;Yonjae Kim;Jae Phil Choi

Frequent Co-Authors

Kyong Ran Peck
Kyong Ran Peck Samsung Medical Center
Doo Ryeon Chung
Doo Ryeon Chung Samsung Medical Center
Jae-Hoon Song
Jae-Hoon Song Samsung Medical Center
Nam Yong Lee
Nam Yong Lee Samsung Medical Center
Kwan Soo Ko
Kwan Soo Ko Sungkyunkwan University
Myoung-don Oh
Myoung-don Oh Seoul National University
Eui Chong Kim
Eui Chong Kim Seoul National University
Po-Ren Hsueh
Po-Ren Hsueh China Medical University
Marcel A. Müller
Marcel A. Müller Charité - University Medicine Berlin
Christian Drosten
Christian Drosten Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, including roles in healthcare, research, and biotechnology. For individuals with unique challenges, exploring options like the best degree for felons can provide valuable guidance on accessible programs that offer promising futures.

Healthcare is a strong sector for microbiology graduates, especially in specialties that blend clinical expertise with patient care. For example, becoming a functional medicine NP is an emerging pathway that integrates microbiology knowledge with holistic treatment approaches.

Another vital area is health information management, where professionals organize and protect sensitive health data. Understanding the scope of a healthcare information manager salary and career trajectory can help microbiology graduates evaluate opportunities beyond the laboratory.

Additionally, certifications like the CPC certification can complement a microbiology background by enhancing skills in medical coding and billing, essential for clinical research and healthcare administration roles.

Best Scientists Citing Cheol-In Kang

Trending Scientists

Recently Published Articles